Category: Correspondence

A Peruvian Paige Figi

Nancy Sajben, MD, forwards a story from the Guardian about a Peruvian mom whose son has Lennox-Gastaut syndrome and is using black-market cannabis oil to alleviate his seizures and other symptoms. Just like Colorado’s Paige Figi and thousands of US parents whose children have seizure disorders, Ana Alvarez is pushing her government to provide safe access now. The Peruvian government and medical establishment are stalling in the name of science. As reported by Dan Collyns: Peru’s leading anti-drugs NGO, Cedro, would only support the use of cannabis oil for children if it contained virtually no THC, the principle mind-altering...

Read More

Background on Cannabis v. Alcohol

“I don’t think I ever had a single shift where at least one of the patients I was taking care of was in that hospital bed at least partially due to their use of alcohol.” —Lanny Swerdlow, RN. Lanny Swerdlow asked in an email  if  “Dr. Mikuriya tried to get the study (Cannabis as a Substitute for Alcohol, which had run in O’Shaughnessy’s) published in a peer-reviewed journal and got turned down?”  Our off-the-top response is hereby corrected and expanded. Thanks to Jerry Mandel, Ethan Russo, MD, and Shobhit Arora, MD, for their input.   Tod had written a case report,...

Read More

The Looming Threat of Zero Tolerance

A Note to the SCC From Steve Robinson, MD: After the passage of the medical cannabis regulation and safety act (MCRSA) in 2015 and Proposition 64 in 2016, the California landscape for cannabis has undergone seismic shifts. MCRSA establishes new agencies and bureaus within the California state government and defines licensing categories for different segments of the industry. It charges the Medical Board of California (MBC) to amend their enforcement priorities to include “excessive recommending of cannabis for medical purposes, or recommending without a good faith prior exam,” and instructs them to consult with the California Center for Medicinal...

Read More

‘Stakeholder Engagement Meeting’ on NAS Report

Sorry for the late notice —the discussion starts at 9:45 a.m. Beltway Time. Do the organizers not know that most of the “stakeholders” they intend to “engage” are living on the Left Coast? Oh, well… As Wanda used to say, “Be there or be in DARE!” On February 21, 2017, the National Academies of Sciences, Engineering, and Medicine (the National Academies) will host an open stakeholder engagement meeting in Washington, D.C., to discuss key messages from the new report, The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research.  The event, which will also be...

Read More

Black Women Ignored as Doulas, Acknowledged as Specimens

Deborah Peterson Small forwarded a piece from NPR with a chilling graphic and this comment: “Important history piece about the role of black women in the development of modern gynecology, as subjects of experimentation……missing is the role of black women as midwives and nurses whose medical knowledge was passed down from generation to generation……all of which was dismissed by European medical professionals who had no respect for the knowledge and practice of black doulas who were often the only health care providers for enslaved women and their children.” Here’s the piece from NPR. org, which aired in February 2016: Remembering...

Read More